Sumitomo Mitsui DS Asset Management Company Ltd Makes New $2.48 Million Investment in Astera Labs, Inc. $ALAB

Sumitomo Mitsui DS Asset Management Company Ltd acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 4th quarter, Holdings Channel.com reports. The firm acquired 14,902 shares of the company’s stock, valued at approximately $2,479,000.

Several other hedge funds have also recently bought and sold shares of the stock. Vanguard Group Inc. lifted its position in Astera Labs by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock worth $2,300,344,000 after acquiring an additional 84,365 shares during the last quarter. State Street Corp lifted its position in Astera Labs by 9.1% during the third quarter. State Street Corp now owns 2,339,451 shares of the company’s stock worth $458,065,000 after acquiring an additional 195,992 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its position in Astera Labs by 46.6% during the third quarter. Massachusetts Financial Services Co. MA now owns 1,507,675 shares of the company’s stock worth $295,203,000 after acquiring an additional 479,360 shares during the last quarter. Amundi lifted its position in Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after acquiring an additional 1,319,643 shares during the last quarter. Finally, Value Aligned Research Advisors LLC lifted its position in Astera Labs by 16.7% during the third quarter. Value Aligned Research Advisors LLC now owns 1,378,351 shares of the company’s stock worth $269,881,000 after acquiring an additional 197,320 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

More Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: JPMorgan raised its price target on Astera Labs to $280 from $205 and kept an overweight rating, signaling strong confidence in further upside after the company’s latest results. Benzinga
• Positive Sentiment: Needham lifted its price target to $260, while other reports cited positive forecasts from JPMorgan and Stifel, adding to the bullish analyst momentum around ALAB. Astera Labs (NASDAQ:ALAB) Price Target Raised to $260.00 at Needham & Company LLC
• Positive Sentiment: Commentary around the stock highlighted Astera Labs as a long-term momentum name and a beneficiary of AI connectivity demand, suggesting investors see durable growth tied to datacenter buildouts and server interconnect products. Why Astera Labs, Inc. (ALAB) is a Top Momentum Stock for the Long-Term
• Positive Sentiment: Several pieces emphasized strong AI connectivity demand and Scorpio expansion, with upbeat takes on the company’s positioning in the datacenter market helping support the stock. Nuts and Bolts AI Play Gains Momentum: Astera Labs Targets Raised
• Neutral Sentiment: Post-earnings analysis was mixed: bulls pointed to strong growth, but critics noted rising costs, competition, and a premium valuation, which could cap near-term upside. Should Investors Buy, Hold, or Sell ALAB Stock Post Q1 Earnings?
• Neutral Sentiment: Astera Labs’ Q1 2026 earnings transcript kept attention on the company’s strong revenue growth and guidance, but the transcript itself does not add a new catalyst beyond the already reported results. Astera Labs (ALAB) Q1 2026 Earnings Transcript
• Negative Sentiment: The main downside risk is valuation: after a strong run and multiple target hikes, some investors may worry the stock already prices in a lot of future growth.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on ALAB shares. Weiss Ratings upgraded shares of Astera Labs from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday. UBS Group started coverage on shares of Astera Labs in a research report on Tuesday, April 21st. They set a “neutral” rating and a $180.00 price objective for the company. Barclays raised their price objective on shares of Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a research report on Thursday. Needham & Company LLC raised their target price on shares of Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday. Finally, TD Cowen raised their target price on shares of Astera Labs from $140.00 to $225.00 and gave the stock a “hold” rating in a report on Wednesday. Fifteen equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $229.65.

Astera Labs Trading Up 2.1%

Shares of ALAB opened at $199.79 on Friday. Astera Labs, Inc. has a 12 month low of $69.26 and a 12 month high of $262.90. The firm’s 50 day moving average is $143.77 and its 200-day moving average is $153.99. The stock has a market capitalization of $34.25 billion, a PE ratio of 134.99, a P/E/G ratio of 3.30 and a beta of 3.35.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. During the same period last year, the firm earned $0.33 earnings per share. The business’s revenue for the quarter was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities research analysts predict that Astera Labs, Inc. will post 1.48 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CFO Michael Truett Tate sold 12,001 shares of Astera Labs stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total value of $1,485,843.81. Following the transaction, the chief financial officer directly owned 192,083 shares of the company’s stock, valued at $23,781,796.23. This trade represents a 5.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, General Counsel Philip Mazzara sold 10,000 shares of Astera Labs stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $107.77, for a total transaction of $1,077,700.00. Following the completion of the transaction, the general counsel directly owned 118,084 shares in the company, valued at $12,725,912.68. This trade represents a 7.81% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,064,888 shares of company stock valued at $150,764,723 over the last three months. 12.50% of the stock is owned by corporate insiders.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.